[
  {
    "ts": "2025-11-15T08:16:26+00:00",
    "headline": "FDA Approves First Generic Omnipaque: Might Change The Case For Investing In Amneal Pharmaceuticals (AMRX)",
    "summary": "Amneal Pharmaceuticals announced that the U.S. FDA has approved its iohexol injection (300 mg Iodine/mL), the first generic version of GE Healthcare's Omnipaque, with plans to launch in the first quarter of 2026 for use in multiple imaging procedures. This marks a significant entry into a US$652 million market and expands Amneal's offering of complex injectable pharmaceuticals, targeting both adult and pediatric patient populations. We'll explore how FDA approval of Amneal's first-to-market...",
    "url": "https://finance.yahoo.com/news/fda-approves-first-generic-omnipaque-081626635.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "923e88cb-06b3-3784-8c4b-e4f3034c273a",
      "content": {
        "id": "923e88cb-06b3-3784-8c4b-e4f3034c273a",
        "contentType": "STORY",
        "title": "FDA Approves First Generic Omnipaque: Might Change The Case For Investing In Amneal Pharmaceuticals (AMRX)",
        "description": "",
        "summary": "Amneal Pharmaceuticals announced that the U.S. FDA has approved its iohexol injection (300 mg Iodine/mL), the first generic version of GE Healthcare's Omnipaque, with plans to launch in the first quarter of 2026 for use in multiple imaging procedures. This marks a significant entry into a US$652 million market and expands Amneal's offering of complex injectable pharmaceuticals, targeting both adult and pediatric patient populations. We'll explore how FDA approval of Amneal's first-to-market...",
        "pubDate": "2025-11-15T08:16:26Z",
        "displayTime": "2025-11-15T08:16:26Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pVOKMAerbRsXv56pHka6Lw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EmyGBi4taxQExvvwka_9KQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/8b2f1fb8ed1ddbd9c7702732b1ea0316.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fda-approves-first-generic-omnipaque-081626635.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-approves-first-generic-omnipaque-081626635.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMRX"
            },
            {
              "symbol": "GEHC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]